Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism.

Abstract

BACKGROUND Pulmonary embolism is a potentially life-threatening condition in which a clot can travel from the deep veins, most commonly in the leg, up to the lungs. Previously, a pulmonary embolism was treated with the anticoagulants heparin and vitamin K antagonists. Recently, however, two forms of direct oral anticoagulants (DOACs) have been developed… (More)
DOI: 10.1002/14651858.CD010957.pub2

Topics

2 Figures and Tables

Blog articles referencing this paper